1 study on Irgd curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study presents a highly promising and innovative strategy for targeted RNAi therapy against pancreatic cancer, leveraging the natural biocompatibility of exosomes and the specificity of the iRGD peptide. By effec…